Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 27;4(4):100563.
doi: 10.1016/j.jacig.2025.100563. eCollection 2025 Nov.

Idiopathic hypereosinophilic syndrome: Potential pathologic somatic gene variants identified by exome sequencing

Alejandro Ferrer  1   2 , Mrunal Dehankar  3 , Saurabh Baheti  3 , Mrinal M Patnaik  1 , Thanai Pongdee  1   4
Affiliations

Idiopathic hypereosinophilic syndrome: Potential pathologic somatic gene variants identified by exome sequencing

Alejandro Ferrer et al. J Allergy Clin Immunol Glob. .

Abstract

Background: Hypereosinophilic syndrome (HES) is a rare group of disorders characterized by eosinophilia in blood and/or tissues. The etiology of HES is largely unknown. Characterizing the molecular pathophysiology of HES may improve diagnostic and therapeutic methodology.

Objective: We sought to identify somatic gene variants associated with idiopathic HES using exome sequencing.

Methods: Exome sequencing (SureSelect capture kit, 80× average depth) was performed using either PBMCs or bone marrow cytogenetic pellets from 31 patients with idiopathic HES. We used Mutect2 in tumor-only mode with gnomAD as the germline resource and FilterMutectCalls for confident somatic variant calling. Variants selected had at least 20 supporting reads, variant allele frequency below 35%, high Clinical Annotation of Variants impact, and minor allele frequency of <1% in gnomAD and Mayo Clinic Biobank.

Results: A total of 332 unique variants in 310 genes were identified at least in 1 patient. Of these, 5 genes were found recurrently mutated (present in at least 10% of samples): PRTFDC1 (16%), TYRO3 (16%), TDG (12.9%), TYW1B (12.9%), and ZNF880 (12.9%). Pathway enrichment analysis using the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology databases utilizing all variants identified in the cohort found significant enrichment in pathways related to cell cycle and PI3K-Akt signaling (Kyoto Encyclopedia of Genes and Genomes) and RAS signal transduction (Gene Ontology).

Conclusions: Several somatic mutations were identified in our cohort of patients with idiopathic HES. Increasing the number of patients through collaborative efforts and pursuing functional testing of these variants will help elucidate the importance of these genes in idiopathic HES.

Keywords: Eosinophil; gene; hypereosinophilic syndrome; sequencing; variant.

PubMed Disclaimer

Conflict of interest statement

This work was supported by a grant from the 10.13039/100014535Center for Individualized Medicine at 10.13039/100000871Mayo Clinic. The funding source played no role in the design, conduct, or reporting of this study. The content of this article is solely the responsibility of the authors and does not represent the official views of Mayo Clinic. Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.

References

    1. Valent P., Klion A.D., Horny H.-P., Roufosse F., Gotlib J., Weller P.F., et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130:607–612.e9. - PMC - PubMed
    1. Ogbogu P.U., Bochner B.S., Butterfield J.H., Gleich G.J., Huss-Marp J., Kahn J.E., et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124:1319–1325.e3. - PMC - PubMed
    1. Mangaonkar A.A., Ferrer A., Vairo F.P., Cousin M.A., Kuisle R.J., Gangat N., et al. Clinical applications and utility of a precision medicine approach for patients with unexplained cytopenias. Mayo Clin Proc. 2019;94:1753–1768. - PMC - PubMed
    1. Münz M., Ruark E., Renwick A., Ramsay E., Clarke M., Mahamdallie S., et al. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting. Genome Med. 2015;7:76. - PMC - PubMed
    1. Rakela J., Rule J., Ganger D., Lau J., Cunningham J., Dehankar M., et al. Whole exome sequencing among 26 patients with indeterminate acute liver failure: a pilot study. Clin Transl Gastroenterol. 2019;10e - PMC - PubMed

LinkOut - more resources